sulfinpyrazone has been researched along with Respiratory Distress Syndrome in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, R | 1 |
1 review available for sulfinpyrazone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
[Adult respiratory distress syndrome (ARDS) (author's transl)].
Topics: Adrenal Cortex Hormones; Alkalosis; Barotrauma; Humans; Hypoxia; Myocardial Infarction; Positive-Pre | 1981 |